Update on antiviral agents for HIV and AIDS.
Drug therapy is a vital component of the care required to promote quality of life for individuals who are afflicted with HIV or AIDS. Issues including weight loss and gain, heart disease, insulin resistance, and even increased bone metabolism must be considered when determining appropriate pharmacologic therapy. New complications often arise with new treatments; living longer may not always mean living better. However, it is the responsibility of nurses to promote the best care possible. Management of appropriate drug therapy and the related implications are critical nursing responsibilities in the care of individuals who have HIV or AIDS.
Covington
Linda W
LW
School of Nursing, Middle Tennessee State University, Murfreesboro, TN 37132, USA. lcovingt@mtsu.edu
D000328:Adult; D000998:Antiviral Agents / Q000145:classification / Q000276:immunology / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D005260:Female; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000276:immunology / Q000523:psychology / Q000628:therapy*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D024802:Nurse's Role; D009730:Nursing Assessment; D009733:Nursing Diagnosis; D010347:Patient Care Planning; D010353:Patient Education as Topic; D018579:Patient Selection; D011480:Protease Inhibitors / Q000627:therapeutic use; D011788:Quality of Life; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019562:Viral Load
D000998:Antiviral Agents; D023581:HIV Fusion Inhibitors; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase